Dale Terasaki, MD, MPH
Assistant Professor, Medicine-Internal Medicine

Professional Titles

• Attending physician, Inpatient addiction consult service
• Faculty member, Addiction medicine fellowship
• Faculty member, Addiction psychiatry fellowship

Recognition & Awards

• Colorado Health Service Corps, Colorado Department of Public Health & Environment (2020)
  3-year service commitment to substance use disorder treatment in high need area
• 5280 Top Doc for Addiction Medicine, 5280 Magazine (2020)

Research Interests

Publications

• Terasaki D. Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder. J Addict Med. 2023 Jan 17. [Epub ahead of print] PubMed PMID: 36728042
• Terasaki D, Brady J. Severe, Nondelirium Agitation as an Underreported Characteristic of Precipitated Fentanyl Withdrawal: A Case Report. J Addict Med. 2023 Jan-Feb 01;17(1):111-113. PubMed PMID: 35914120
• Terasaki D. Cardiovascular medications on discharge for patients with chest pain and concurrent cocaine use. Am J Emerg Med. 2022 Mar 4;. doi: 10.1016/j.ajem.2022.02.060. [Epub ahead of print] PubMed PMID: 35279327.
• Terasaki D, Shaffie R, Loh R (2022). Characteristics of hospitalized patients whose substance use increased amid the impacts of COVID-19. The Hospitalist. Online publication. March 3, 2022. Available at: https://www.the-hospitalist.org/
• Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 Nov 22;17(1):64. PubMed PMID: 36419181
• Terasaki D. Cardiovascular medications on discharge for patients with chest pain and concurrent cocaine use. Am J Emerg Med. 2022 Aug;58:315-316. PubMed PMID: 35279327
• Mortaji P, Terasaki D, Moo-Young J. Advanced Inpatient Management of Opioid Use Disorder in a Patient Requiring Serial Surgeries. J Gen Intern Med. 2021 Aug;36(8):2448-2451. PubMed PMID: 33782885
• Terasaki D (2021). Methadone disposition on a Friday. SGIM Forum 44 (8): 8, 12.
• Terasaki D & Klie K. Tramadol withdrawal in setting of buprenorphine induction, a case report. Journal of Addiction Medicine. May/Jun 2020;14(3):264-266.
• Terasaki, D. (2019) Clinical Harm Reduction for Addiction: A Strategy Internists Can (And Do) Embrace. SGIM Forum 42 (9): 5, 9.
• Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 Oct;39(10):1023-1029. PubMed PMID: 31348544

Professional Memberships

• American Society of Addiction Medicine, Member